ALSO READIndices end at record high: Sensex up 286 pts, Nifty ends above 10950 Sensex ends flat, Nifty closes below 10,400 ahead of F&O expiry, Q2 GDP Sensex ends flat, Nifty below 9,800; broader markets underperform Markets end at record closing high; Nifty hits 10,500, ends lower Sensex ends 270 points lower, Nifty below 9,850 as Infosys cracks 9%
Nifty top gainer: Nifty Pharma Index Markets Check Index Current Pt. Change % Change S&P BSE SENSEX 34,413.16 +330.45 +0.97 S&P BSE SENSEX 50 11,026.92 +108.24 +0.99 S&P BSE SENSEX Next 50 34,632.14 +596.51 +1.75 S&P BSE 100 10,958.39 +120.39 +1.11 S&P BSE Bharat 22 Index 3,712.43 +12.53 +0.34 (Source: BSE) Sectoral Trend Sensex heatmap Markets at close Benchmark indices rose more than 1 per cent on Thursday after seven consecutive sessions of declines, as market heavyweights such as Infosys recovered and as drug maker Cipla gained on solid earnings. The S&P BSE Sensex ended at 34,413, up nearly 330 points while the broader Nifty50 index settled at 10,576, up around 100 points. Pharma shares in focus; Cipla, Sun Pharma surge over 5% Shares of pharmaceutical companies were in focus with the Nifty Pharma index gaining nearly 4% on back of strong rally in Cipla and Cadila Healthcare post their December quarter results. Among the pharma index, Cipla and Sun Pharmaceutical Industries have rallied more than 5% each, while Cadila Healthcare, Dr Reddy’s Laboratories and Divi’s Laboratories up in the range of 2% to 4% on the National Stock Exchange (NSE). READ MORE
Among other index stocks, Sun Pharma, Dr. Reddy's, State Bank of India, Axis Bank and HDFC gained between 1.5% to 6.1%. Shares of Cipla surged as much as 6.85% after the country’s fourth-largest drugmaker by revenue reported a 7% jump in quarterly profit on Wednesday.